Nursing: Anticoagulants and Antiplatelet Therapy

22.95
Online
Elective

About the Course


Audience: The target audience for this educational course is Advanced Nurse Practitioners.


Learning Objectives

  1. Identify one step in the sequence of forming a platelet plug.
  2. Name one key organ where tissue factor can be located.
  3. Identify the most commonly used antiplatelet medication.
  4. Describe the most common adverse events encountered when using antiplatelet, anticoagulation or thrombolytic medications.
  5. Explain why prasugrel is hypothesized to deliver more consistent results than some alternative drugs in its category.
  6. Provide a rationale for why some patients ultimately stabilized on warfarin for anticoagulation may require initial therapy with a heparin product.
  7. Offer two pieces of advice that nurse practitioners can provide their patients to reduce the risk of bleeding if they are using antiplatelet, anticoagulation or thrombolytic medications.
  8. Explain why weight-based dosing is appropriate for tenecteplase.

 

About the Author

Brad Gillespie, PharmD

Trained as a clinical pharmacist, Brad has practiced in an industrial setting for the past 20-plus years. His initial role was as a clinical pharmacology and biopharmaceutics reviewer at FDA, followed by 15 years of leading early development programs in the pharma/biotech/nutritional industries. In addition to his industrial focus, he remains a registered pharmacist and enjoys mentoring drug development scientists and health professionals, as well as leading workshops and developing continuing education programs for pharmacy, nursing and other medical professionals.


Want Unlimited CE? Become a Member

Nursing: Anticoagulants and Antiplatelet Therapy

22.95

About the Course


Audience: The target audience for this educational course is Advanced Nurse Practitioners.


Learning Objectives

  1. Identify one step in the sequence of forming a platelet plug.
  2. Name one key organ where tissue factor can be located.
  3. Identify the most commonly used antiplatelet medication.
  4. Describe the most common adverse events encountered when using antiplatelet, anticoagulation or thrombolytic medications.
  5. Explain why prasugrel is hypothesized to deliver more consistent results than some alternative drugs in its category.
  6. Provide a rationale for why some patients ultimately stabilized on warfarin for anticoagulation may require initial therapy with a heparin product.
  7. Offer two pieces of advice that nurse practitioners can provide their patients to reduce the risk of bleeding if they are using antiplatelet, anticoagulation or thrombolytic medications.
  8. Explain why weight-based dosing is appropriate for tenecteplase.

 

About the Author

Brad Gillespie, PharmD

Trained as a clinical pharmacist, Brad has practiced in an industrial setting for the past 20-plus years. His initial role was as a clinical pharmacology and biopharmaceutics reviewer at FDA, followed by 15 years of leading early development programs in the pharma/biotech/nutritional industries. In addition to his industrial focus, he remains a registered pharmacist and enjoys mentoring drug development scientists and health professionals, as well as leading workshops and developing continuing education programs for pharmacy, nursing and other medical professionals.